Targeting Nuclear EGFR: Strategies for Improving Cetuximab Therapy in Lung Cancer

doi 10.21236/ada599892
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Nuclear EGFR Contributes to Acquired Resistance to Cetuximab

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Targeting EGFR-mediated Autophagy as a Potential Strategy for Cancer Therapy

International Journal of Cancer
Cancer ResearchOncology
2018English

mTOR Co-Targeting Strategies for Head and Neck Cancer Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2017English

Combined Therapy With EGFR TKI and Gambogic Acid for Overcoming Resistance in EGFR‑T790M Mutant Lung Cancer

Oncology Letters
Cancer ResearchOncology
2015English

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery
Oncology
2014English

Docosahexaenoic Acid Monoglyceride Increases Carboplatin Activity in Lung Cancer Models by Targeting EGFR

Anticancer Research
MedicineCancer ResearchOncology
2017English

EGFR Kinase Domain Mutations – Functional Impact and Relevance for Lung Cancer Therapy

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Targeting Glucose Metabolism With 2-Deoxy-D-Glucose for Improving Cancer Therapy

Future Oncology
MedicineCancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy